ADC Therapeutics SA at Cowen Healthcare Conference (Virtual) Transcript
Welcome, everybody, to our next fireside chat. It's my pleasure to host Chris Martin from ADC Therapeutics.
Questions & Answers
So Chris, let's just dive right in. You guys are -- by the name of your company, are focused on the antibody drug conjugates. Can you just discuss the PBD-based antibody drug conjugates? What makes them different from some of the other approaches out there?
Certainly, Boris. The PBDs were developed specifically to be active in tumor cells, which were either primary refractory or had acquired resistance. They're very potent. They're at least 100x more potent than drugs like the auristatins, mytomycins, (inaudible), which themselves, of course, are much more potent than systemic chemotherapeutics. But the really important thing
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
